RxDoctor Payments Data

Stephen Kovach, MD

Plastic Surgery · Philadelphia, PANPI 1255463683

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Davol Inc. accounts for 69.2% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $228,408, 2.6 times the $86,596 reported in 2019. Among plastic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$825,213in general payments, 2019–2025

Across 608 payments — averaging $1357.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$571K
  • Integra Lifesciences Corporation$118K
  • W. L. Gore & Associates, Inc.$81K
  • Checkpoint Surgical, Inc$23K
  • AbbVie$16K
  • C. R. Bard, Inc. & Subsidiaries$7K
  • plus $10K from 16 others
$2,278in research payments, 2019–2025

Across 2 payments — averaging $1139.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Davol Inc.$2K

What the payments were for

  • Consulting fees$265,34132%
  • Speaking & faculty fees$474,60758%
  • Travel & lodging$66,9818%
  • Food & beverage$18,2832%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$825,213 in reported general payments places this provider in the 95th percentile of 196 plastic surgery providers in Pennsylvania.

See all plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$379,801
Medicare patients
240
Services billed
1,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →